Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 41,923 shares at $403.08 ($16.8M) on 2025-09-15, disclosed to the SEC on 2025-09-17.
Scheduled sale ($16.8M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $396.87 | 105 | $42K | 0.2% |
| 2 | $396.95 | 295 | $117K | 0.7% |
| 3 | $396.95 | 295 | $117K | 0.7% |
| 4 | $397.96 | 820 | $326K | 1.9% |
| 5 | $397.96 | 820 | $326K | 1.9% |
| 6 | $398.02 | 1,380 |
| $549K |
| 3.3% |
| 7 | $398.02 | 1,380 | $549K | 3.3% |
| 8 | $399.07 | 1,415 | $565K | 3.4% |
| 9 | $399.07 | 1,415 | $565K | 3.4% |
| 10 | $399.20 | 920 | $367K | 2.2% |
| 11 | $400.09 | 2,910 | $1.2M | 6.9% |
| 12 | $400.09 | 2,910 | $1.2M | 6.9% |
| 13 | $400.24 | 2,289 | $916K | 5.5% |
| 14 | $400.24 | 2,289 | $916K | 5.5% |
| 15 | $400.79 | 5,103 | $2.0M | 12.2% |
| 16 | $400.79 | 5,103 | $2.0M | 12.2% |
| 17 | $400.86 | 2,068 | $829K | 4.9% |
| 18 | $400.86 | 2,068 | $829K | 4.9% |
| 19 | $402.06 | 1,470 | $591K | 3.5% |
| 20 | $402.06 | 1,470 | $591K | 3.5% |
| 21 | $402.12 | 668 | $269K | 1.6% |
| 22 | $402.12 | 668 | $269K | 1.6% |
| 23 | $403.00 | 2,052 | $827K | 4.9% |
| 24 | $403.08 | 1,005 | $405K | 2.4% |
| 25 | $403.08 | 1,005 | $405K | 2.4% |
| Total | $400.48 avg | 41,923 | $16.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |